Co-treatment with quercetin and 1,2,3,4,6-penta- O -galloyl-β- d -glucose causes cell cycle arrest and apoptosis in human breast cancer MDA-MB-231 and AU565 cells

Journal of Agricultural and Food Chemistry

Volumn 61, Issue 26, 2013, Pages 6430-6445

  Huang, Cheng ^a   Lee, Suz Yi ^b   Lin, Chih Li ^c   Tu, Tzu Huei ^b   Chen, Ling Hsuan ^b   Chen, Yi Jing ^b   Huang, Hsiu Chen ^b  

^a NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

^b NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

5GG; AU565; MDA MB231; Que; synergistic effect

Indexed keywords

5GG; AU565; MDA-MB231; QUE; SYNERGISTIC EFFECT;

CELL CULTURE; CELL DEATH; CELL GROWTH; FLAVONOIDS; PHENOLS;

DISEASES;

ANTINEOPLASTIC AGENT; ANTIOXIDANT; BETA-PENTA-O-GALLOYL-GLUCOSE; GLUCOSE PENTAGALLATE; QUERCETIN; TANNIN;

APOPTOSIS; ARTICLE; BREAST TUMOR; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTIOXIDANTS; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; G2 PHASE CELL CYCLE CHECKPOINTS; HUMANS; HYDROLYZABLE TANNINS; QUERCETIN;

EID: 84879768648     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf305253m     Document Type: Article

References (44)

1. Morabito, A.; Magnani, E.; Gion, M.; Sarmiento, R.; Capaccetti, B.; Longo, R.; Gattuso, D.; Gasparini, G. Prognostic and predictive indicators in operable breast cancer Clin. Breast Cancer 2003, 3 (6) 381-390
2. Signoretti, S.; Di Marcotullio, L.; Richardson, A.; Ramaswamy, S.; Isaac, B.; Rue, M.; Monti, F.; Loda, M.; Pagano, M. Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer J. Clin. Invest. 2002, 110 (5) 633-641
3. Olszewski, W. Clinical efficacy of micronized purified flavonoid fraction (MPFF) in edema Angiology 2000, 51 (1) 25-29
4. Walle, T.; Vincent, T. S.; Walle, U. K. Evidence of covalent binding of the dietary flavonoid quercetin to DNA and protein in human intestinal and hepatic cells Biochem. Pharmacol. 2003, 65 (10) 1603-1610
5. Schlachterman, A.; Valle, F.; Wall, K. M.; Azios, N. G.; Castillo, L.; Morell, L.; Washington, A. V.; Cubano, L. A.; Dharmawardhane, S. F. Combined resveratrol, quercetin, and catechin treatment reduces breast tumor growth in a nude mouse model Transl. Oncol. 2008, 1 (1) 19-27
6. Kim, Y. H.; Lee, D. H.; Jeong, J. H.; Guo, Z. S.; Lee, Y. J. Quercetin augments TRAIL-induced apoptotic death: involvement of the ERK signal transduction pathway Biochem. Pharmacol. 2008, 75 (10) 1946-1958
7. Ramos, A. M.; Aller, P. Quercetin decreases intracellular GSH content and potentiates the apoptotic action of the antileukemic drug arsenic trioxide in human leukemia cell lines Biochem. Pharmacol. 2008, 75 (10) 1912-1923
8. Wang, P.; Zhang, K.; Zhang, Q.; Mei, J.; Chen, C. J.; Feng, Z. Z.; Yu, D. H. Effects of quercetin on the apoptosis of the human gastric carcinoma cells Toxicol. in Vitro 2011, 26 (2) 221-228
9. Djuric, Z.; Severson, R. K.; Kato, I. Association of dietary quercetin with reduced risk of proximal colon cancer Nutr. Cancer 2012, 64 (3) 351-360
10. Hayashi, Y.; Matsushima, M.; Nakamura, T.; Shibasaki, M.; Hashimoto, N.; Imaizumi, K.; Shimokata, K.; Hasegawa, Y.; Kawabe, T. Quercetin protects against pulmonary oxidant stress via heme oxygenase-1 induction in lung epithelial cells Biochem. Biophys. Res. Commun. 2012, 417 (1) 169-174
11. Gibellini, L.; Pinti, M.; Nasi, M.; Montagna, J. P.; De Biasi, S.; Roat, E.; Bertoncelli, L.; Cooper, E. L.; Cossarizza, A. Quercetin and cancer chemoprevention Evid. Based Complementary Altern. Med. 2011, 591356
12. Staedler, D.; Idrizi, E.; Kenzaoui, B. H.; Juillerat-Jeanneret, L. Drug combinations with quercetin: doxorubicin plus quercetin in human breast cancer cells Cancer Chemother. Pharmacol. 2011, 68 (5) 1161-1172
13. Tang, S. N.; Singh, C.; Nall, D.; Meeker, D.; Shankar, S.; Srivastava, R. K. The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition J. Mol. Signaling 2010, 5, 14
14. Russo, M.; Spagnuolo, C.; Tedesco, I.; Bilotto, S.; Russo, G. L. The flavonoid quercetin in disease prevention and therapy: facts and fancies Biochem. Pharmacol. 2012, 83 (1) 6-15
15. Kwon, T. R.; Jeong, S. J.; Lee, H. J.; Sohn, E. J.; Jung, J. H.; Kim, J. H.; Jung, D. B.; Lu, J.; Kim, S. H. Reactive oxygen species-mediated activation of JNK and down-regulation of DAXX are critically involved in penta-O-galloyl-beta-d-glucose-induced apoptosis in chronic myeloid leukemia K562 cells Biochem. Biophys. Res. Commun. 2012, 424 (3) 530-537
16. Lee, H. J.; Seo, N. J.; Jeong, S. J.; Park, Y.; Jung, D. B.; Koh, W.; Lee, E. O.; Ahn, K. S.; Lu, J.; Kim, S. H. Oral administration of penta-O-galloyl-beta-D-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition Carcinogenesis 2011, 32 (6) 804-811
17. Hu, H.; Zhang, J.; Lee, H. J.; Kim, S. H.; Lu, J. Penta-O-galloyl-beta-D- glucose induces S- and G(1)-cell cycle arrests in prostate cancer cells targeting DNA replication and cyclin D1 Carcinogenesis 2009, 30 (5) 818-823
18. Ryu, H. G.; Jeong, S. J.; Kwon, H. Y.; Lee, H. J.; Lee, E. O.; Lee, M. H.; Choi, S. H.; Ahn, K. S.; Kim, S. H. Penta-O-galloyl-beta-D-glucose attenuates cisplatin-induced nephrotoxicity via reactive oxygen species reduction in renal epithelial cells and enhances antitumor activity in Caki-2 renal cancer cells Toxicol. in Vitro 2011, 26 (2) 206-214
19. Shimizu, K.; Kamiya, O.; Hamajima, N.; Mizuno, H.; Kobayashi, M.; Hirabayashi, N.; Takeyama, H.; Kato, R.; Kawashima, K.; Nitta, M. Multi-drug combination therapy with vincristine-melphalan-cyclophosphamide-prednisolone was more effective than cyclophosphamide-prednisolone in stage III myeloma. The Nagoya Myeloma Cooperative Study Group Jpn. J. Cancer Res. 1990, 81 (12) 1320-1327
20. Kontoyiannis, D. P.; Lewis, R. E. Toward more effective antifungal therapy: the prospects of combination therapy Br. J. Hamaetol. 2004, 126 (2) 165-175
21. Salucci, M.; Stivala, L. A.; Maiani, G.; Bugianesi, R.; Vannini, V. Flavonoids uptake and their effect on cell cycle of human colon adenocarcinoma cells (Caco2) Br. J. Cancer 2002, 86 (10) 1645-1651
22. Saijo, R.; Nonaka, G.; Nishioka, I. Tannins and related compounds. LXXXIV. Isolation and characterization of five new hydrolyzable tannins from the bark of Mallotus japonicus Chem. Pharm. Bull. (Tokyo) 1989, 37 (8) 2063-2070
23. Yu, D.; Jing, T.; Liu, B.; Yao, J.; Tan, M.; McDonnell, T. J.; Hung, M. C. Overexpression of ErbB2 blocks Taxol-induced apoptosis by upregulation of p21Cip1, which inhibits p34Cdc2 kinase Mol. Cell 1998, 2 (5) 581-591
24. Barre, B.; Perkins, N. D. The Skp2 promoter integrates signaling through the NF-kappaB, p53, and Akt/GSK3beta pathways to regulate autophagy and apoptosis Mol. Cell 2010, 38 (4) 524-538
25. Schneider, G.; Saur, D.; Siveke, J. T.; Fritsch, R.; Greten, F. R.; Schmid, R. M. IKKalpha controls p52/RelB at the skp2 gene promoter to regulate G1- to S-phase progression EMBO J. 2006, 25 (16) 3801-3812
26. Bashir, T.; Dorrello, N. V.; Amador, V.; Guardavaccaro, D.; Pagano, M. Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase Nature 2004, 428 (6979) 190-193
27. Muth, D.; Ghazaryan, S.; Eckerle, I.; Beckett, E.; Pohler, C.; Batzler, J.; Beisel, C.; Gogolin, S.; Fischer, M.; Henrich, K. O.; Ehemann, V.; Gillespie, P.; Schwab, M.; Westermann, F. Transcriptional repression of SKP2 is impaired in MYCN-amplified neuroblastoma Cancer Res. 2010, 70 (9) 3791-3802
28. Shin, J. S.; Hong, S. W.; Lee, S. L.; Kim, T. H.; Park, I. C.; An, S. K.; Lee, W. K.; Lim, J. S.; Kim, K. I.; Yang, Y.; Lee, S. S.; Jin, D. H.; Lee, M. S. Serum starvation induces G1 arrest through suppression of Skp2-CDK2 and CDK4 in SK-OV-3 cells Int. J. Oncol. 2008, 32 (2) 435-439
29. Nicolini, A.; Giardino, R.; Carpi, A.; Ferrari, P.; Anselmi, L.; Colosimo, S.; Conte, M.; Fini, M.; Giavaresi, G.; Berti, P.; Miccoli, P. Metastatic breast cancer: an updating Biomed. Pharmacother. 2006, 60 (9) 548-556
30. Lin, H. K.; Chen, Z.; Wang, G.; Nardella, C.; Lee, S. W.; Chan, C. H.; Yang, W. L.; Wang, J.; Egia, A.; Nakayama, K. I.; Cordon-Cardo, C.; Teruya-Feldstein, J.; Pandolfi, P. P. Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence Nature 2010, 464 (7287) 374-379
31. Yokoi, S.; Yasui, K.; Mori, M.; Iizasa, T.; Fujisawa, T.; Inazawa, J. Amplification and overexpression of SKP2 are associated with metastasis of non-small-cell lung cancers to lymph nodes Am. J. Pathol. 2004, 165 (1) 175-180
32. Hung, W. C.; Tseng, W. L.; Shiea, J.; Chang, H. C. Skp2 overexpression increases the expression of MMP-2 and MMP-9 and invasion of lung cancer cells Cancer Lett. 2010, 288 (2) 156-161
33. Hu, R.; Aplin, A. E. Skp2 regulates G2/M progression in a p53-dependent manner Mol. Biol. Cell 2008, 19 (11) 4602-4610
34. Kitagawa, M.; Lee, S. H.; McCormick, F. Skp2 suppresses p53-dependent apoptosis by inhibiting p300 Mol. Cell 2008, 29 (2) 217-231
35. Scambia, G.; Ranelletti, F. O.; Benedetti Panici, P.; Piantelli, M.; Bonanno, G.; De Vincenzo, R.; Ferrandina, G.; Pierelli, L.; Capelli, A.; Mancuso, S. Quercetin inhibits the growth of a multidrug-resistant estrogen-receptor-negative MCF-7 human breast-cancer cell line expressing type II estrogen-binding sites Cancer Chemother. Pharmacol. 1991, 28 (4) 255-258
36. Ghosh, N.; Ghosh, R.; Mandal, V.; Mandal, S. C. Recent advances in herbal medicine for treatment of liver diseases. Pharm. Biol. 2011, 49 (9), 970-988.
37. Greenwald, P. Clinical trials in cancer prevention: current results and perspectives for the future J. Nutr. 2004, 134 (12 Suppl) 3507S-3512S
38. Chan, C. H.; Li, C. F.; Yang, W. L.; Gao, Y.; Lee, S. W.; Feng, Z.; Huang, H. Y.; Tsai, K. K.; Flores, L. G.; Shao, Y.; Hazle, J. D.; Yu, D.; Wei, W.; Sarbassov, D.; Hung, M. C.; Nakayama, K. I.; Lin, H. K. The Skp2-SCF E3 ligase regulates Akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis Cell 2012, 149 (5) 1098-1111
39. Altenburg, J. D.; Bieberich, A. A.; Terry, C.; Harvey, K. A.; Vanhorn, J. F.; Xu, Z.; Jo Davisson, V.; Siddiqui, R. A. A synergistic antiproliferation effect of curcumin and docosahexaenoic acid in SK-BR-3 breast cancer cells: unique signaling not explained by the effects of either compound alone BMC Cancer 2011, 11, 149
40. Wang, P.; Heber, D.; Henning, S. M. Quercetin increased bioavailability and decreased methylation of green tea polyphenols in vitro and in vivo Food Funct. 2012, 3 (6) 635-642
41. Wang, P.; Heber, D.; Henning, S. M. Quercetin increased the antiproliferative activity of green tea polyphenol (-)-epigallocatechin gallate in prostate cancer cells Nutr. Cancer 2011, 64 (4) 580-587
42. Nalepa, G.; Wade Harper, J. Therapeutic anti-cancer targets upstream of the proteasome Cancer Treat Rev. 2003, 29 (Suppl 1) 49-57
43. Mao, C.; Yang, Z. Y.; He, B. F.; Liu, S.; Zhou, J. H.; Luo, R. C.; Chen, Q.; Tang, J. L. Toremifene versus tamoxifen for advanced breast cancer Cochrane Database Syst. Rev. 2012, 7, CD008926
44. Kumar, R.; Verma, V.; Jain, A.; Jain, R. K.; Maikhuri, J. P.; Gupta, G. Synergistic chemoprotective mechanisms of dietary phytoestrogens in a select combination against prostate cancer J. Nutr. Biochem. 2011, 22 (8) 723-731